Abstract:Molecular imprinting technique is used to develop an imprinted β‐CD polymer using LPA as template. This MIP prepared was imprinted with LPA cavity, which has been extended for Raman spectroscopy. MIP is prepared from adduct by washing LPA template with solvent. The LPA is removed and a particular cavity of a template is imprinted in a polymer. The cavity is complementary to the shape and size of the template molecule (LPA). The capacity of developed MIPs to detect LPA in serum samples that have been spiked is also observed. Lysophosphatidic acid (LPA) has significant potential as a biomarker for diagnosis of ovarian cancer in female patients because it is present throughout all phases of the illness. Regrettably, there is not a clinically useful test for this biomarker yet. In this work, an ultra‐detection of LPA molecule by Raman spectroscopy‐based molecularly imprinted polymer (MIP) in serum samples is reported. β‐CD was synthesized to facilitate the collection of Raman spectroscopy and combined with MIP to denote it as β‐CD‐MIP for the adsorption of LPA with high sensitivity and selectivity. Linear regression model in serum samples shows peaks at 1100 and 1116 cm−1, respectively. A satisfactory linear fit was seen with LPA concentration log I = 3.7 log C + 1255.74 and with spiked serum log I = 4.6 log C + 327.22, respectively. The literature survey suggests the threshold LPA level in healthy person is 1.50 μM/L whereas the LPA level rises in patients with benign ovarian cancer tumor as 7.90 μM/L. This LPA level rises to 16.99 μM/L in ovarian cancer patients. On the basis of the band intensity, the limit of detection of the β‐CD‐MIP sensor for LPA was recorded as 0.003 μM/L. The binding constant of β‐CD‐MIP for LPA in serum was 0.031–0.003 μM/L, respectively. β‐CD‐MIP gel was optimized, characterized, and successfully applied on spiked serum samples. The findings of this research show that this substrate has a lot of potential for ultradetection of trace amounts of LPA molecule from the serum samples. The MIP sensor is robust, recyclable, efficient, and selective.

Production and Application of Lpa Polyclonal Antibody

Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column.

Preparation and Identification of Polyclonal Antibodies Against LPTS

Quantitative determination of cyclic phosphatidic acid in human serum by LC/ESI/MS/MS.

Near-Infrared Fluorogenic Probes with Polarity-Sensitive Emission for in Vivo Imaging of an Ovarian Cancer Biomarker

Ultrasensitive and specific fluorescence detection of a cancer biomarker via nanomolar binding to a guanidinium-modified calixarene.

Design and Characterization of a Dual-Protein Strategy for an Early-Stage Assay of Ovarian Cancer Biomarker Lysophosphatidic Acid

A study of diagnostic value of plasma lysophosphatidic acid for ovarian epithelial cancer

Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid Using a Label-Free Electrochemical Biosensor

Clinical Evaluation on the Determination of Plasma Lysophosphatidic Acid Concentration in Chinese Human Pancreatic Cancer

Aptameric System for the Highly Selective and Ultrasensitive Detection of Protein in Human Serum Based on Non-Stripping Gold Nanoparticles

Raman spectroscopy‐based molecularly imprinted polymer sensor for sensitive detection of lysophosphatidic acid in serum

Biotinylated Au Nanoparticle-Based Artificial Antibody for Detection of Lysozyme by the Lateral Flow Immunoassay and Enzyme-Linked Immunosorbent Assay

Dually Crosslinked Supramolecular Hydrogel for Cancer Biomarker Sensing

One-step and label-free detection of alpha-fetoprotein based on aggregation of gold nanorods

Highly Sensitive Protein Detection Using Enzyme-Labeled Gold Nanoparticle Probes.

Preparation and Characterization of A Polyclonal Antibody Against Marine Polysaccharide from Filamentous Fungus Phoma Herbarum YS4108

High-Density Gold Nanoparticles Implanted on Mg/Fe LDH Nanoflowers Assisted Lateral Flow Immuno-Dipstick Assay for Visual Detection of Human Epididymal Protein 4

A Dual Gold Nanoparticle Conjugate-Based Lateral Flow Assay (LFA) Method for the Analysis of Human Serum Osteocalcin

AgPd NPs-based Lateral flow immunoassay for simultaneous detection of glycocholic acid and alpha-fetoprotein

An Accurate and Amplifying Competitive Lateral Flow Immunoassay for the Sensitive Detection of Haptens